Article info

Download PDFPDF
Correspondence
Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation

Authors

  1. Correspondence to Dr Matthew Smith, Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK; matthew.smith{at}bartshealth.nhs.uk
View Full Text

Citation

Spencer Chapman M, Araf S, Smith M
Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation

Publication history

  • Received August 9, 2015
  • Revised September 26, 2015
  • Accepted September 30, 2015
  • First published October 21, 2015.
Online issue publication 
February 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.